On July 15, 2015, an Ohio resident and his wife filed an Actos bladder cancer lawsuit against both Takeda Pharmaceuticals and Eli Lilly, Inc. alleging severely inadequate warnings as to the increased risks associated with the Type II diabetes drug. The lawsuit, which was filed in United States District Court... Read more »

On July 1, 2015, a West Virginia-based plaintiff filed a personal injury and product liability lawsuit alleging that the drugs AndroGel and Axiron caused the onset of a pulmonary embolism – and the defendants failed to properly warn him of this known risk. The lawsuit was filed within the established multidistrict... Read more »

On June 22, 2015, Health Canada – an entity organized under the Government of Canada to help citizens maintain and improve their health – initiated a safety review of the drugs Farxiga and Invokana, which are both used to help control the blood sugar levels of patients diagnosed with Type... Read more »

Over the past several years, the number of testosterone replacement therapy products prescribed to men approaching senior citizen status has literally soared – reaching sales topping $9 billion. The culprit? The apparent onset of the condition known as “low-t,” or low testosterone – a condition believed by some in the... Read more »

The controversial blood thinning drug Xarelto has been named in yet another lawsuit – this time, tragically, following the death of an elderly Missouri resident who was prescribed the medication by his treating physician in December, 2012. Xarelto has been targeted with increasing scrutiny over the past several years, and... Read more »

Presently, there are over 800 AndroGel lawsuits pending against manufacturer AbbVie, all of which are seeking compensation for expenses and damages incurred as a result of alleged side effects linked to the testosterone therapy. These claims, which have been consolidated along with other lesser-known claims against testosterone replacement products, are awaiting... Read more »

On March 27, 2015, a former Risperdal patient filed a lawsuit in U.S. District Court for the Eastern District of Louisiana against several drug manufacturers, including Janssen Pharmaceuticals and Johnson & Johnson. The complaint is one of several ongoing causes of action against the makers of the powerful antipsychotic drug, which... Read more »

In a recent complaint against Zofran manufacturer GlaxoSmithKline (GSK), two Montana parents have alleged significant failures by GSK to properly warn women of the allegedly known risks of congenital birth defects in babies exposed to the drug in utero. The complaint includes the full history of the testing and approval of... Read more »

For patients suffering from the condition known as atrial fibrillation – or “A-fib” – an anti-coagulant drug is often used to help prevent the formation of deadly blood clots. For generations, doctors prescribed the drug known as warfarin to A-fib patients, until the newer blood thinning drug Xarelto was introduced... Read more »

The diabetes drug Actos has been named in several thousand product liability lawsuits across the United States. Accordingly, the cases have been consolidated pursuant to the rules of multidistrict litigation (MDL) – a process which funnels near-identical civil lawsuits into a single litigation tract for purposes of eliminating duplicative routine... Read more »